Clinical Trial Update: Daylight-PDT With MAL for AK and Photodamaged Skin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for daylight-prefred PDT with MAL in actinic keratoses and photodamaged skin; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Photodamaged Skin

Drugs mentioned

• Daylight-PDT with MAL (methyl aminolevulinate (MAL) daylight PDT)

Snippet

Sponsor: University Hospital Regensburg | Conditions: Actinic Keratoses, Photodamaged Skin | Phase 4 | Status: COMPLETED